AARTI INDUSTRIES
Prabhudas Lilladhar
Broker Research reports: Sell reports
for all stocks
- This broker has downgraded this stock from it's previous report. (eg. - Buy->Hold)
- Broker has maintained previous recommendation but reduced share price target.
- This broker has upgraded this stock from it's previous report.(eg. - Sell->Hold)
- Broker has maintained previous recommendation but increased share price target.
RESEARCH REPORTS ALERTS
Load latest
Google or static link led you to an intermediate page.
- All Recent
- Upside
- Buy
- Sell
- Recent Upgrades
- Recent Downgrades
- IPO
- Sector Updates
- Most Recent
- Top Upside
Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.
| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04 Feb 2025 | Aarti Industries |
Prabhudas Lilladhar
|
399.75 | 411.00 | 456.00 (-12.34%) | Target met |
Sell
|
||||
| 03 Feb 2025 | Greenlam Industries |
BOB Capital Markets Ltd.
|
225.45 | 500.00 | 562.80 (-59.94%) | Target met |
Sell
|
||||
| 01 Feb 2025 | V-Mart Retail |
CD Equisearch
|
3268.40 | 2408.00 | 3397.40 (-3.80%) | 26.32 |
Sell
|
||||
| 31 Jan 2025 | Relaxo Footwears |
Motilal Oswal
|
407.10 | 425.00 | 549.45 (-25.91%) | Target met |
Sell
|
||||
| 31 Jan 2025 | Ajanta Pharma |
BOB Capital Markets Ltd.
|
2694.60 | 2288.00 | 2694.45 (0.01%) | 15.09 |
Sell
|
||||
| 30 Jan 2025 | Tatva Chintan Pharma |
KRChoksey
|
722.00 | 761.00 | 775.95 (-6.95%) | Target met |
Sell
|
Outlook remains uncertain with lack of visibility in the key SDA segment
KRChoksey
TATVA revenue missed our estimates due to significant decline in SDA segment. EBITDA beat our estimates due to lower-than-expected cost of goods sold and operating expenses. However, Adj PAT missed our estimates significantly due to higher-than-expected depreciation, lower than expected other income.
|
|||
| 30 Jan 2025 | Colgate-Palmolive |
KRChoksey
|
2570.50 | 2721.00 | 2771.30 (-7.25%) | Target met |
Sell
|
Intense competition and subdued demand constrained growth
KRChoksey
For Q3FY25, the revenue increased to 4.7% YoY (-9.7% QoQ) to INR 14,618 Mn, which missed our estimate by 3.9%. The company YoY growth, driven by toothpaste sales which showed mid-single digit volume growth.
|
|||
| 29 Jan 2025 | Gujarat Fluorochemicals |
Prabhudas Lilladhar
|
3968.00 | 3190.00 | 3536.90 (12.19%) | 19.61 |
Sell
|
||||
| 29 Jan 2025 | Petronet LNG |
Prabhudas Lilladhar
|
303.95 | 276.00 | 301.40 (0.85%) | Target met |
Sell
|
||||
| 28 Jan 2025 | Balkrishna Industries |
KRChoksey
|
2503.90 | 2528.00 | 2706.15 (-7.47%) | Target met |
Sell
|
Resilient performance amidst challenges; Near-term headwinds persist
KRChoksey
• Company Q3FY25’s earnings performance exceeds our estimates across the board.
• For Q3FY25, BIL reported revenue of INR 25,603 Mn (+12.6% YoY/ +5.8% QoQ), which outperformed our estimates by 4.3%. |
|||
|
more
loading
|
|||||||||||
* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.